Fluctuating blood sugar levels from diabetes can increase the risk of yeast overgrowth, characterized by symptoms such as itching and unusual discharge
A12, another mAb, demonstrated promise in preclinical studies by inhibiting cancer cell growth, but requires further research (228, 229)
In inhaled delivery applications, PEG lipids may undergo size changes and aggregation upon nebulization 177 , and their effects on lipid hydration and membrane structure warrant consideration 178
Patent and life-cycle strategy : formulary leverage is increasingly tied to secondary patents (compositions, dosing regimens, delivery devices, and method-of-treatment claims), plus exclusivity shields (regulatory exclusivities in key jurisdictions)
Categorical variables were compared using the 2 test